Literature DB >> 2996497

Mast-cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte/macrophages.

J R Yoffe, D J Taylor, D E Woolley.   

Abstract

Purified mast cells derived from rat peritoneal fluids and dog mastocytomas were extracted with 1 M-NaCl and sonication techniques. The mast-cell products increased the production of mononuclear cell factor from human peripheral blood mononuclear cells in culture, as judged by the enhanced stimulation of prostaglandin E (2-5 fold) and collagenase (3-11-fold) production by cultured adherent synovial cells. Heparin alone (1-10 micrograms/ml) induced a similar stimulation of mononuclear-cell-factor production by monocyte cultures, whereas histamine (1-10 micrograms/ml) had no effect. The stimulatory effect of mast-cell products and heparin represented a direct effect on mononuclear cells; they did not potentiate the effect of monokine on the synovial cells. These results suggest that mast-cell-macrophage interactions may play a significant role in the pathogenesis of inflammation and connective-tissue degradation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996497      PMCID: PMC1152589          DOI: 10.1042/bj2300083

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Mast cells and metachromasia in human breast cancer: their occurrence, significance and consequence: a preliminary report.

Authors:  F Hartveit
Journal:  J Pathol       Date:  1981-05       Impact factor: 7.996

Review 2.  Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion.

Authors:  S M Krane
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

3.  Heparin receptors on mouse macrophages.

Authors:  I Bleiberg; I MacGregor; M Aronson
Journal:  Thromb Res       Date:  1983-01-01       Impact factor: 3.944

4.  Polysaccharides with sulfate groups are human T-cell mitogens and murine polyclonal B-cell activators (PBAs). I. Fucoidan and heparin.

Authors:  I Sugawara; S Ishizaka
Journal:  Cell Immunol       Date:  1982-11-15       Impact factor: 4.868

5.  Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxis.

Authors:  M Baggiolini; U Horisberger; U Martin
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

6.  Modulation of synovial cell products by a factor from a human cell line: T lymphocyte induction of a mononuclear cell factor.

Authors:  E P Amento; J T Kurnick; A Epstein; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Interactions among rheumatoid synovial cells and monocyte-macrophages: production of collagenase-stimulating factor by human monocytes exposed to concanavalin A or immunoglobulin Fc fragments.

Authors:  J M Dayer; J H Passwell; E E Schneeberger; S M Krane
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

8.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

Review 9.  Granulocyte elastase at the site of cartilage erosion by rheumatoid synovial tissue.

Authors:  H Menninger; R Putzier; W Mohr; D Wessinghage; K Tillmann
Journal:  Z Rheumatol       Date:  1980 May-Jun       Impact factor: 1.372

10.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  12 in total

1.  Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts.

Authors:  M K Dabbous; S M North; L Haney; D A Tipton; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

2.  Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation.

Authors:  M K Dabbous; D E Woolley; L Haney; L M Carter; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1986 Apr-Jun       Impact factor: 5.150

Review 3.  Mast cells in rheumatoid arthritis.

Authors:  Nicola Maruotti; Enrico Crivellato; Francesco Paolo Cantatore; Angelo Vacca; Domenico Ribatti
Journal:  Clin Rheumatol       Date:  2006-05-31       Impact factor: 2.980

4.  Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro.

Authors:  L C Tetlow; N Harper; T Dunningham; M A Morris; H Bertfield; D E Woolley
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

5.  Mechanism of the modulation of murine peritoneal cell function and mast cell degranulation by low doses of malathion.

Authors:  K Rodgers; D Ellefson
Journal:  Agents Actions       Date:  1992-01

Review 6.  Collagenolytic mechanisms in tumor cell invasion.

Authors:  D E Woolley
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Serum IgE anti-cartilage collagen antibodies in rheumatoid patients.

Authors:  J S Bartholomew; J M Evanson; D E Woolley
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II.

Authors:  K Suzuki; M Lees; G F Newlands; H Nagase; D E Woolley
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

9.  Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

10.  Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma.

Authors:  M K Dabbous; R Walker; L Haney; L M Carter; G L Nicolson; D E Woolley
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.